(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Market Buzz: Bullish Narrative for Liquid Media, Tarsus Pharma, Vertiv, and Neogen

  • June 17th, 2023
  • 245 views

Shares of Liquid Media Group Ltd. (Nasdaq: YVR) experienced a notable surge of over 11% in after-hours trading Friday as the company revealed the sale of its wholly-owned subsidiary, IndieFlix Group, for a total purchase price of US$1.2 million.

The purchase price was structured as a ten-year promissory note (secured by all the shares of IndieFlix Group) with an interest rate of 6.0%. Payments under the note will commence 18 months from issuance, with 10% of IndieFlix Group's gross monthly revenues being applied towards the payments.

$YVR was trading at $0.18 in after-hours.

Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS), a biopharmaceutical company focused on developing and commercializing innovative therapies for ophthalmic conditions, had its Buy rating maintained by Guggenheim. The investment firm also raised the price target for TARS from $40 to $42. 

Despite $TARS closing at $18.51 on Friday, the adjusted price target implies a potential upside of $23.49 or 126.80%, according to the investment and advisory firm's analysis.

Vertiv Holdings Co. (NYSE: VRT), a global provider of critical digital infrastructure and continuity solutions, had its Buy rating upheld by Citigroup, accompanied by a price target increase from $21 to $29. 

Considering Friday's closing price of $22.54, the revised price target suggests a potential upside of $6.46 or 28.68% for $VRT, based on the investment firm's view. 

Neogen Corporation (Nasdaq: NEOG), a leading provider of food and animal safety solutions, received coverage initiation from Wells Fargo with an Overweight rating and a price target of $22. 

With $NEOG closing at $20.77 on Friday, the announced price target indicates a potential upside of $1.23 or 5.92%, as per the financial services firm's analysis.

The potential upsides mentioned are based on the perspectives of brokerage firms, investment firms, or analysts. It's important for investors to conduct their own research and analysis before making any investment decisions. The actual potential upsides may vary, and thorough evaluation of the companies' fundamentals and market conditions is crucial for informed decision-making.

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13